Back to Trades
Gold Kelly
Chief Financial OfficerCIK 0002033333
Profile
- Filings
- 7
- Buy transactions
- 3
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Gold Kelly, Chief Financial Officer, has filed 7 SEC reports (2025–2026), spread across 2 companies, totaling $2.6M in disclosed volume. Weighing $60.4K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $39.6K in Camp4 Therapeutics Corp. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Sep 2 | CAMP Camp4 Therapeutics Corp | Gold Kelly | Chief Financial Officer | Buy | $39.6K |
| Aug 5 | CAMP Camp4 Therapeutics Corp | Gold Kelly | Chief Financial Officer | Buy | $10.8K |
| Jul 1 | XFOR X4 Pharmaceuticals, Inc | Gold Kelly | Director | Award | $449.4K |
| Jul 1 | XFOR X4 Pharmaceuticals, Inc | Gold Kelly | Director | Other | $0 |
| Apr 3 | CAMP Camp4 Therapeutics Corp | Gold Kelly | Chief Financial Officer | Award | $958.9K |
| Dec 22 | CAMP Camp4 Therapeutics Corp | Gold Kelly | Chief Financial Officer | Award | $1.1M |
| Sep 11 | CAMP Camp4 Therapeutics Corp | Gold Kelly | Chief Financial Officer | Buy | $10.0K |
7 filings